Concepedia

Kathryn Van Hook

KV

Statistics

Publications

5

Citations

129

H-Index

5

Active since

2012

Affiliations

Oregon Health & Science University(Current)

Kathryn Van Hook is an author at Oregon Health & Science University specializing in medicine, oncology, and pharmacology.

Publications per year

2012–2017

5

Publications

5

N terminus of ASPP2 binds to Ras and enhances Ras/Raf/MEK/ERK activation to promote oncogene-induced senescence

Zhiping Wang, Yuangang Liu, Maho Takahashi et al. · Proceedings of the National Academy of Sciences · 2012 · 57 citations · Full text

, , +17

Cellular androgen content influences enzalutamide agonism of F877L mutant androgen receptor

Daniel J. Coleman, Kathryn Van Hook, Carly J. King et al. · Oncotarget · 2016 · 22 citations · Full text

, , +15

Orteronel for the Treatment of Prostate Cancer

Kathryn Van Hook, Ted Huang, Joshi J. Alumkal · Future Oncology · 2014 · 20 citations · Full text

, , +17

ΔN-ASPP2, a novel isoform of the ASPP2 tumor suppressor, promotes cellular survival

Kathryn Van Hook, Zhiping Wang, Dexi Chen et al. · Biochemical and Biophysical Research Communications · 2016 · 15 citations

, , +16

Integrative molecular network analysis identifies emergent enzalutamide resistance mechanisms in prostate cancer

Carly J. King, Josha Woodward, Jacob Schwartzman et al. · Oncotarget · 2017 · 15 citations · Full text

, , +16

1–5 of 5